25 June 2020: The Federal Ministers give a final decision (positive) for this trial
Trial reference:
A first-in human, Phase 1b/2, study to evaluate the safety, tolerability and immunogenicity of HPV viral vectored vaccines in women with low-grade HPV-related cervical lesions